Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
Subscribe to see Micro Interventional Devices, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Micro Interventional Devices, Inc. is a medical devices company headquartered in United States. It has raised at least $17.5M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round raised $14M in December 2022. Xcout tracks 6 named people at Micro Interventional Devices, Inc., including Michael Whitman (President and CEO).
At least $17.5M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $14M | — | |
| Series B | $3.5M | — | |
| Seed | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Micro Interventional Devices, Inc.'s closest competitors — see the full list of competitors and alternatives →
Capstan Medical is a medical-device company developing minimally invasive, catheter-based systems for transcatheter mitral valve replacement. Its technology is intended for patients with mitral valve disease and the clinicians who treat them, particularly those who may be at elevated risk for open-heart surgery.
HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.
TRiCares is a medical device company with global offices that designs and develops specialized structural heart treatments and catheter-based valve repair systems.
Nido Surgical, LLC is a Boston-based medical device company developing the SEPIA device, an innovative solution designed for cardiac epicardial ablation. The company also focuses on creating minimally invasive instruments for image-guided, beating-heart surgery, including tools for video-endoscopic trans-cardiac surgical repairs.
Valtech Cardio was an Israeli medical-device company developing minimally invasive transcatheter technologies for treating mitral valve disease, including the Cardioband mitral annuloplasty system. Its products were intended for cardiologists and patients with mitral regurgitation, and the company was acquired by Edwards Lifesciences in 2017.
Trisol Medical is a medical equipment manufacturing company headquartered in Yokneam, Israel. The company specializes in the design and development of medical device concepts aimed at addressing unmet clinical needs in treating Tricuspid Valve insufficiency.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.